Assertio (ASRT) Competitors

scPharmaceuticals (NASDAQ:SCPH) and Assertio (NASDAQ:ASRT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Which has preferable valuation & earnings, SCPH or ASRT?

Assertio has higher revenue and earnings than scPharmaceuticals. scPharmaceuticals is trading at a lower price-to-earnings ratio than Assertio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
scPharmaceuticals	$49.97M	5.16	-$85.15M	-$1.81	-2.67
Assertio	$117.10M	0.69	-$21.58M	-$0.45	-1.88

Is SCPH or ASRT more profitable?

Assertio has a net margin of -36.97% compared to scPharmaceuticals' net margin of -183.55%. Assertio's return on equity of -36.06% beat scPharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
scPharmaceuticals	-183.55%	-1,647.86%	-71.76%
Assertio	-36.97%	-36.06%	-15.33%

Does the media refer more to SCPH or ASRT?

In the previous week, Assertio had 4 more articles in the media than scPharmaceuticals. MarketBeat recorded 14 mentions for Assertio and 10 mentions for scPharmaceuticals. scPharmaceuticals' average media sentiment score of 0.02 beat Assertio's score of -0.18 indicating that scPharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
scPharmaceuticals	1 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Assertio	0 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Which has more risk and volatility, SCPH or ASRT?

scPharmaceuticals has a beta of 0.4, meaning that its stock price is 60% less volatile than the S&P 500. Comparatively, Assertio has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of SCPH or ASRT?

89.5% of scPharmaceuticals shares are held by institutional investors. Comparatively, 49.0% of Assertio shares are held by institutional investors. 4.8% of scPharmaceuticals shares are held by company insiders. Comparatively, 4.0% of Assertio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Do analysts rate SCPH or ASRT?

scPharmaceuticals currently has a consensus price target of $14.00, suggesting a potential upside of 189.32%. Assertio has a consensus price target of $2.38, suggesting a potential upside of 181.40%. Given scPharmaceuticals' higher probable upside, equities analysts plainly believe scPharmaceuticals is more favorable than Assertio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
scPharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Assertio	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Assertio beats scPharmaceuticals on 8 of the 15 factors compared between the two stocks.